Strom Law Firm Columbia SC
No obligations & no credit card required

Roundup Cancer Lawsuit

Landmark Roundup Cancer Lawsuit  Trial Ends in $289 Million Award to Plaintiff

Monsanto took a massive hit following a California jury’s decision in a Roundup Cancer Lawsuit to award a former groundskeeper just shy of $290 million in a landmark case alleging the company’s Roundup® weed killer causes cancer. The jurors ruled that Roundup and Ranger Pro products presented a “substantial danger” to the now 46-year-old Dewayne “Lee” Johnson, who developed non-Hodgkin’s lymphoma after using the spray for more than 2 years as a groundskeeper in California.


What is Roundup®?

Roundup is a non-selective herbicide used to kill weeds that compete with agricultural crops. Glyphosate, the active ingredient in Roundup, works by inhibiting a specific enzyme required for plant growth.

By 2001, Roundup weed killer was the most-used active ingredient in American agriculture, with an estimated 85-90 million pounds used each year. In 2007, that number reached 185 million pounds annually and today, Roundup remains the most widely used herbicide in the United States and worldwide.

Roundup Cancer Lawsuit

Roundup and Cancer

A number of  Roundup® cancer studies have found evidence linking the weed killer’s main ingredient, glyphosate, to serious side effects. The most serious Roundup side effects include Non-Hodgkin Lymphoma.

Our product liability Roundup Lawyers are skilled in dealing with the various obstacles that arise during the course of your case.

 Although many of the people we assist in these cases are from here in South Carolina, we regularly help clients from throughout the United States. If you or someone close to you were exposed to Monsanto’s Roundup® and have been diagnosed with non-Hodgkin lymphoma, you may be entitled to financial compensation. , contact the Strom Law Firm, L.L.C. today about a Roundup® Lawsuit. We are happy to provide a free consultation with one of our attorneys.803-252-4800

Roundup® Cancer Lawsuit

Share:

Facebook
Twitter
LinkedIn
Categories
Archives

Follow us

Sign Up For Our Newsletter!